SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

SECTION 1. IDENTIFICATION
Product name:Recombinant Follicle Stimulating Hormone Formulation

Manufacturer or supplier's details
Company name of supplier: Organon & Co.
Address: 30 Hudson Street, 33nd floor
Jersey City, New Jersey, U.S.A 07302
Telephone: 1-551-430-6000
Emergency telephone: 1-215-631-6999
E-mail address: EHSSTEWARD@organon.com
Recommended use of the chemical and restrictions on use
Recommended use: Pharmaceutical
Restrictions on use: Not applicable
SECTION 2. HAZARDS IDENTIFICATIONGHS classification in accordance with the OSHA Hazard Communication Standard (29 CFR
1910.1200)
Reproductive toxicity: Category 1BSpecific target organ toxicity- repeated exposure:

Category 1 (male reproductive organs, female reproductive organs)

GHS label elements
Hazard pictograms:

Signal Word:

DangerHazard Statements:

H360FD May damage fertility. May damage the unborn child.
H372 Causes damage to organs (male reproductive organs,
female reproductive organs) through prolonged or repeatedexposure.

Precautionary Statements:

Prevention:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been readand understood.
P260 Do not breathe mist or vapors.
P264 Wash skin thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves, protective clothing, eye protection
and face protection.
Response:
1 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

P308 + P313 IF exposed or concerned: Get medical attention.
Storage:
P405 Store locked up.
Disposal:
P501 Dispose of contents and container to an approved waste
disposal plant.
Other hazards
None known.
SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance / Mixture:

MixtureComponents
Chemical name
CAS-No.
Sucrose57-50-1
Benzyl alcohol
100-51-6
Recombinant Follicle Stimulating
146479-72-3
HormoneActual concentration is withheld as a trade secretConcentration (% w/w)>= 5 - < 10>= 1 - < 5>= 0.1 - < 1

SECTION 4. FIRST AID MEASURES
General advice:

In the case of accident or if you feel unwell, seek medical
advice immediately.
When symptoms persist or in all cases of doubt seek medical
advice.

If inhaled:

In case of skin contact:

In case of eye contact:

If swallowed:

Most important symptoms
and effects, both acute anddelayedProtection of first-aiders:

Notes to physician:

If inhaled, remove to fresh air.
Get medical attention.
In case of contact, immediately flush skin with soap and plentyof water.
Remove contaminated clothing and shoes.
Get medical attention.
Wash clothing before reuse.
Thoroughly clean shoes before reuse.
Flush eyes with water as a precaution.
Get medical attention if irritation develops and persists.
If swallowed, DO NOT induce vomiting.
Get medical attention.
Rinse mouth thoroughly with water.
May damage fertility. May damage the unborn child.
Causes damage to organs through prolonged or repeatedexposure.
First Aid responders should pay attention to self-protection,and use the recommended personal protective equipment
when the potential for exposure exists (see section 8).
Treat symptomatically and supportively.

:

2 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

SECTION 5. FIRE-FIGHTING MEASURES
Suitable extinguishing media:

Unsuitable extinguishingmedia
Specific hazards during firefighting
Hazardous combustion products:

Water spray
Alcohol-resistant foam
Carbon dioxide (CO2)
Dry chemical
None known.

:

Exposure to combustion products may be a hazard to health.

:

Carbon oxides
Metal oxides

Specific extinguishing methods:

Special protective equipment
for fire-fighters:

Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.
Use water spray to cool unopened containers.
Remove undamaged containers from fire area if it is safe to doso.
Evacuate area.
In the event of fire, wear self-contained breathing apparatus.
Use personal protective equipment.

SECTION 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protec- :tive equipment and emergency procedures

Use personal protective equipment.
Follow safe handling advice (see section 7) and personal
protective equipment recommendations (see section 8).

Environmental precautions:

Avoid release to the environment.
Prevent further leakage or spillage if safe to do so.
Prevent spreading over a wide area (e.g., by containment or
oil barriers).
Retain and dispose of contaminated wash water.
Local authorities should be advised if significant spillages
cannot be contained.

Methods and materials forcontainment and cleaning up:

Soak up with inert absorbent material.
For large spills, provide diking or other appropriate
containment to keep material from spreading. If diked material
can be pumped, store recovered material in appropriate
container.
Clean up remaining materials from spill with suitable
absorbent.
Local or national regulations may apply to releases anddisposal of this material, as well as those materials and items
employed in the cleanup of releases. You will need todetermine which regulations are applicable.
Sections 13 and 15 of this SDS provide information regarding
certain local or national requirements.

SECTION 7. HANDLING AND STORAGE
3 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Technical measures:

Local/Total ventilation:

Advice on safe handling:

Conditions for safe storage:

Materials to avoid:

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

See Engineering measures under EXPOSURE
CONTROLS/PERSONAL PROTECTION section.
If sufficient ventilation is unavailable, use with local exhaust
ventilation.
Do not get on skin or clothing.
Do not breathe mist or vapors.
Do not swallow.
Avoid contact with eyes.
Wash skin thoroughly after handling.
Handle in accordance with good industrial hygiene and safety
practice, based on the results of the workplace exposure
assessment
Keep container tightly closed.
Do not eat, drink or smoke when using this product.
Take care to prevent spills, waste and minimize release to theenvironment.
Keep in properly labeled containers.
Store locked up.
Keep tightly closed.
Store in accordance with the particular national regulations.
Do not store with the following product types:
Strong oxidizing agents
Self-reactive substances and mixtures
Organic peroxides
Explosives
Gases

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Ingredients with workplace control parameters
Components

CAS-No.

Sucrose57-50-1

Benzyl alcohol
Recombinant Follicle Stimulating Hormone

Engineering measures

100-51-6
146479-72-3:

Value type
(Form ofexposure)
TWA
TWA (Respirable)
TWA (total)
TWA (total
dust)
TWA (respirable fraction)
TWA
TWA

Control parameters / Permissible
concentration
10 mg/m³
5 mg/m³

Basis

10 mg/m³
15 mg/m³

NIOSH REL
OSHA Z-1

5 mg/m³

OSHA Z-1

10 ppm
5 μg/m3 (OEB 4)US WEELInternal

Wipe limit

50 μg/100 cm²Internal

ACGIH
NIOSH REL

Minimize workplace exposure concentrations.
If sufficient ventilation is unavailable, use with local exhaust
ventilation.

4 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

Personal protective equipment
Respiratory protection: General and local exhaust ventilation is recommended tomaintain vapor exposures below recommended limits. Where
concentrations are above recommended limits or are
unknown, appropriate respiratory protection should be worn.
Follow OSHA respirator regulations (29 CFR 1910.134) anduse NIOSH/MSHA approved respirators. Protection provided
by air purifying respirators against exposure to any
hazardous chemical is limited. Use a positive pressure air
supplied respirator if there is any potential for uncontrolled
release, exposure levels are unknown, or any othercircumstance where air purifying respirators may not provide
adequate protection.
Hand protection
Material:

Chemical-resistant gloves

Remarks:

Eye protection:

Skin and body protection:

Hygiene measures:

Choose gloves to protect hands against chemicals dependingon the concentration specific to place of work. Breakthroughtime is not determined for the product. Change gloves often!
For special applications, we recommend clarifying theresistance to chemicals of the aforementioned protective
gloves with the glove manufacturer. Wash hands before
breaks and at the end of workday.
Wear the following personal protective equipment:
Safety glasses
Select appropriate protective clothing based on chemical
resistance data and an assessment of the local exposure
potential.
Skin contact must be avoided by using impervious protective
clothing (gloves, aprons, boots, etc).
If exposure to chemical is likely during typical use, provide
eye flushing systems and safety showers close to theworking place.
When using do not eat, drink or smoke.
Wash contaminated clothing before re-use.

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance:

liquidColor:

No data available

Odor

:

No data available

Odor Threshold:

No data available

pH:

No data available

Melting point/freezing point:

No data available

Initial boiling point and boiling:

No data available
5 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

range
Flash point:

No data available

Evaporation rate:

No data available

Flammability (solid, gas):

Not applicable

Flammability (liquids):

No data available

Upper explosion limit / Upper
flammability limit:

No data available

Lower explosion limit / Lower
flammability limit:

No data available

Vapor pressure:

No data available

Relative vapor density:

No data available

Density:

No data available

Solubility(ies)
Water solubility:

No data available

Partition coefficient: noctanol/water
Autoignition temperature:

No data available:

No data available

Decomposition temperature:

No data available

Viscosity
Viscosity, dynamic:

No data available

Viscosity, kinematic:

No data available

Explosive properties:

Not explosive

Oxidizing properties:

The substance or mixture is not classified as oxidizing.

Molecular weight:

No data available

Particle size:

No data available

SECTION 10. STABILITY AND REACTIVITY
Reactivity
Chemical stability
Possibility of hazardous reactions:::

Not classified as a reactivity hazard.
Stable under normal conditions.
Can react with strong oxidizing agents.

6 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Conditions to avoid
Incompatible materials
Hazardous decomposition
products:::

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

None known.
Oxidizing agents
No hazardous decomposition products are known.

SECTION 11. TOXICOLOGICAL INFORMATION
Information on likely routes of exposure
Inhalation
Skin contact
Ingestion
Eye contact
Acute toxicity
Not classified based on available information.
Product:
Acute oral toxicity:

Acute toxicity estimate: > 5,000 mg/kg
Method: Calculation method

Acute inhalation toxicity:

Acute toxicity estimate: > 200 mg/l
Exposure time: 4 h
Test atmosphere: dust/mist
Method: Calculation method

Sucrose:Acute oral toxicity:

LD50 (Rat): 29,700 mg/kg

Benzyl alcohol:
Acute oral toxicity:

LD50 (Rat): 1,620 mg/kg

Acute inhalation toxicity:

LC50 (Rat): > 4.178 mg/l
Exposure time: 4 h
Test atmosphere: dust/mist
Method: OECD Test Guideline 403

Components:

Recombinant Follicle Stimulating Hormone:Acute toxicity (other routes of : LD50 (Rat): > 0.290 mg/kg
administration)
Application Route: Intravenous
LD50 (Monkey): > 0.290 mg/kg
Application Route: Intravenous
Skin corrosion/irritation
Not classified based on available information.

7 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

Components:
Benzyl alcohol:
Species
MethodResult:::RabbitOECD Test Guideline 404
No skin irritation

Serious eye damage/eye irritation
Not classified based on available information.
Components:
Benzyl alcohol:
SpeciesResult
Method:::RabbitIrritation to eyes, reversing within 21 days
OECD Test Guideline 405

Respiratory or skin sensitization
Skin sensitization
Not classified based on available information.
Respiratory sensitization
Not classified based on available information.
Components:
Benzyl alcohol:
Test Type
Routes of exposure
Species
MethodResult:::::Maximization Test
Skin contact
Guinea pig
OECD Test Guideline 406
negative

Germ cell mutagenicity
Not classified based on available information.
Components:
Sucrose:Genotoxicity in vitro:

Test Type: In vitro mammalian cell gene mutation test
Result: negative

Benzyl alcohol:
Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative

Genotoxicity in vivo:

Test Type: Mammalian erythrocyte micronucleus test (in vivo
cytogenetic assay)
Species: Mouse
Application Route: Intraperitoneal injection
8 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

Result: negative
Recombinant Follicle Stimulating Hormone:
Genotoxicity in vitro: Test Type: Ames test
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Test system: mammalian cells
Result: negative
Test Type: Chromosomal aberration
Test system: Human lymphocytes
Result: negative
Genotoxicity in vivo:

Test Type: Micronucleus test
Species: Mouse
Result: negative

Carcinogenicity
Not classified based on available information.
Components:
Benzyl alcohol:
Species
Application RouteExposure time
MethodResult

:
:
:
:
:

Mouse
Ingestion
103 weeks
OECD Test Guideline 451
negative

IARC

No ingredient of this product present at levels greater than or equal to 0.1% isidentified as probable, possible or confirmed human carcinogen by IARC.

OSHA

No component of this product present at levels greater than or equal to 0.1% is
on OSHA’s list of regulated carcinogens.

NTP

No ingredient of this product present at levels greater than or equal to 0.1% isidentified as a known or anticipated carcinogen by NTP.

Reproductive toxicity
May damage fertility. May damage the unborn child.
Components:
Benzyl alcohol:
Effects on fertility:

Test Type: Fertility/early embryonic development
Species: Rat
Application Route: Ingestion
Result: negative
Remarks: Based on data from similar materials

9 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

Effects on fetal development

SDS Number:
26821-00023:

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

Test Type: Embryo-fetal development
Species: Mouse
Application Route: Ingestion
Result: negative

Recombinant Follicle Stimulating Hormone:
Effects on fertility: Test Type: Fertility
Species: Rat
Application Route: Subcutaneous
Fertility: LOAEL: 0.11
Symptoms: Effect on estrous cycle, Increase of early resorptions., Reduced fertility
Result: positive
Test Type: Fertility
Species: Rabbit
Application Route: Subcutaneous
Fertility: LOAEL: 0.027
Symptoms: Reduced fertility, Reduced embryonic survival
Result: positive
Effects on fetal development:

Test Type: Development
Species: Rat
Application Route: Subcutaneous
Dose: 2.9 µg/kg
Result: positive, No teratogenic effects.

Reproductive toxicity - Assessment:

Clear evidence of adverse effects on sexual function andfertility, based on animal experiments., Clear evidence ofadverse effects on development, based on animal
experiments.

STOT-single exposure
Not classified based on available information.
STOT-repeated exposure
Causes damage to organs (male reproductive organs, female reproductive organs) through prolonged or repeated exposure.
Components:
Recombinant Follicle Stimulating Hormone:Target Organs: male reproductive organs, female reproductive organs
Assessment: Causes damage to organs through prolonged or repeatedexposure.

10 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

Repeated dose toxicity
Components:
Benzyl alcohol:
Species
NOAEL
Application RouteExposure time
Method

:
:
:
:
:

Rat
1.072 mg/l
inhalation (dust/mist/fume)
28 Days
OECD Test Guideline 412

Recombinant Follicle Stimulating Hormone:
Species: Monkey
NOAEL: 0.17 mg/kg
LOAEL: 0.86 mg/kg
Application Route: Subcutaneous
Exposure time: 13 Weeks
Number of exposures: daily
Target Organs: Reproductive organs
Remarks: No significant adverse effects were reported
Species
LOAEL
Exposure timeTarget Organs
Remarks

:
:
:
:
:

Rat
0.14 mg/kg
13 Weeks
Endocrine system
No significant adverse effects were reported

Species
LOAEL
Exposure timeTarget Organs
Remarks

:
:
:
:
:

Dog
0.14 mg/kg
13 Weeks
TestisNo significant adverse effects were reported

Species
NOAEL
LOAEL
Application RouteExposure timeTarget Organs

:
:
:
:
:
:

Rat
0.028 mg/kg
0.28 mg/kg
Subcutaneous
1 yearTestisSpecies
LOAEL
Exposure timeTarget Organs

:
:
:
:

Monkey, male
0.028 mg/kg
1 yearTestisAspiration toxicity
Not classified based on available information.

11 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

Experience with human exposure
Components:
Recombinant Follicle Stimulating Hormone:
Inhalation: Symptoms: gynecomastia, Skin disorders, Headache, Nausea, Vomiting, Diarrhea
SECTION 12. ECOLOGICAL INFORMATION
Ecotoxicity
Components:
Benzyl alcohol:
Toxicity to fish:

LC50 (Pimephales promelas (fathead minnow)): 460 mg/l
Exposure time: 96 h

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): 230 mg/l
Exposure time: 48 h
Method: OECD Test Guideline 202

Toxicity to algae/aquaticplants:

EC50 (Pseudokirchneriella subcapitata (green algae)): 770
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201
NOEC (Pseudokirchneriella subcapitata (green algae)): 310
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201

Toxicity to daphnia and other :aquatic invertebrates (Chronic toxicity)

NOEC (Daphnia magna (Water flea)): 51 mg/l
Exposure time: 21 d
Method: OECD Test Guideline 211

Persistence and degradability
Components:
Benzyl alcohol:
Biodegradability:

Result: Readily biodegradable.
Biodegradation: 92 - 96 %Exposure time: 14 d:

Pow: < 1

Bioaccumulative potential
Components:
Sucrose:Partition coefficient: noctanol/water

12 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

Benzyl alcohol:
Partition coefficient: noctanol/water

SDS Number:
26821-00023:

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

log Pow: 1.05

Mobility in soil
No data available
Other adverse effects
No data available
SECTION 13. DISPOSAL CONSIDERATIONS
Disposal methods
Waste from residues:

Contaminated packaging:

Dispose of in accordance with local regulations.
Do not dispose of waste into sewer.
Empty containers should be taken to an approved waste
handling site for recycling or disposal.
If not otherwise specified: Dispose of as unused product.

SECTION 14. TRANSPORT INFORMATIONInternational Regulations
UNRTDG
Not regulated as a dangerous good
IATA-DGR
Not regulated as a dangerous good
IMDG-CodeNot regulated as a dangerous goodTransport in bulk according to Annex II of MARPOL 73/78 and the IBC CodeNot applicable for product as supplied.
Domestic regulation
49 CFR
Not regulated as a dangerous goodSpecial precautions for user
Not applicable
SECTION 15. REGULATORY INFORMATIONCERCLA Reportable Quantity
This material does not contain any components with a CERCLA RQ.
SARA 304 Extremely Hazardous Substances Reportable Quantity
This material does not contain any components with a section 304 EHS RQ.
SARA 302 Extremely Hazardous Substances Threshold Planning Quantity
This material does not contain any components with a section 302 EHS TPQ.
13 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

SARA 311/312 Hazards:

Reproductive toxicity
Specific target organ toxicity (single or repeated exposure)

SARA 313:

This material does not contain any chemical components withknown CAS numbers that exceed the threshold (De Minimis)
reporting levels established by SARA Title III, Section 313.

US State Regulations
Pennsylvania Right To Know
Water
SucroseBenzyl alcohol7732-18-5
57-50-1
100-51-6

California Permissible Exposure Limits for Chemical Contaminants
Sucrose57-50-1

The ingredients of this product are reported in the following inventories:
AICS: not determinedDSL:

not determined

IECSC

:

not determined

SECTION 16. OTHER INFORMATION
Further information
NFPA 704:

HMIS® IV:
Flammability

HEALTH1
Health00Special hazard*

3

FLAMMABILITY

1

PHYSICAL HAZARD

0

Instability

HMIS® ratings are based on a 0-4 rating
scale, with 0 representing minimal hazards or risks, and 4 representing significant hazards or risks. The "*" represents
a chronic hazard, while the "/" represents
the absence of a chronic hazard.

Full text of other abbreviations
14 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

ACGIH
NIOSH REL
OSHA Z-1:::

US WEEL
ACGIH / TWA
NIOSH REL / TWA:::

OSHA Z-1 / TWA
US WEEL / TWA::

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

USA. ACGIH Threshold Limit Values (TLV)
USA. NIOSH Recommended Exposure Limits
USA. Occupational Exposure Limits (OSHA) - Table Z-1 Limits for Air Contaminants
USA. Workplace Environmental Exposure Levels (WEEL)
8-hour, time-weighted averageTime-weighted average concentration for up to a 10-hour
workday during a 40-hour workweek
8-hour time weighted average
8-hr TWAAIIC - Australian Inventory of Industrial Chemicals; ASTM - American Society for the Testing ofMaterials; bw - Body weight; CERCLA - Comprehensive Environmental Response, Compensation,and Liability Act; CMR - Carcinogen, Mutagen or Reproductive Toxicant; DIN - Standard of theGerman Institute for Standardisation; DOT - Department of Transportation; DSL - Domestic Substances List (Canada); ECx - Concentration associated with x% response; EHS - Extremely Hazardous Substance; ELx - Loading rate associated with x% response; EmS - Emergency Schedule;
ENCS - Existing and New Chemical Substances (Japan); ErCx - Concentration associated with
x% growth rate response; ERG - Emergency Response Guide; GHS - Globally Harmonized System; GLP - Good Laboratory Practice; HMIS - Hazardous Materials Identification System; IARC International Agency for Research on Cancer; IATA - International Air Transport Association; IBC- International Code for the Construction and Equipment of Ships carrying Dangerous Chemicals
in Bulk; IC50 - Half maximal inhibitory concentration; ICAO - International Civil Aviation Organization; IECSC - Inventory of Existing Chemical Substances in China; IMDG - International Maritime
Dangerous Goods; IMO - International Maritime Organization; ISHL - Industrial Safety and Health
Law (Japan); ISO - International Organisation for Standardization; KECI - Korea Existing Chemicals Inventory; LC50 - Lethal Concentration to 50 % of a test population; LD50 - Lethal Dose to
50% of a test population (Median Lethal Dose); MARPOL - International Convention for the Prevention of Pollution from Ships; MSHA - Mine Safety and Health Administration; n.o.s. - Not Otherwise Specified; NFPA - National Fire Protection Association; NO(A)EC - No Observed (Adverse)
Effect Concentration; NO(A)EL - No Observed (Adverse) Effect Level; NOELR - No Observable
Effect Loading Rate; NTP - National Toxicology Program; NZIoC - New Zealand Inventory ofChemicals; OECD - Organization for Economic Co-operation and Development; OPPTS - Officeof Chemical Safety and Pollution Prevention; PBT - Persistent, Bioaccumulative and Toxic substance; PICCS - Philippines Inventory of Chemicals and Chemical Substances; (Q)SAR - (Quantitative) Structure Activity Relationship; RCRA - Resource Conservation and Recovery Act;REACH - Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals; RQ - Reportable
Quantity; SADT - Self-Accelerating Decomposition Temperature; SARA - Superfund Amendments and Reauthorization Act; SDS - Safety Data Sheet; TCSI - Taiwan Chemical SubstanceInventory; TECI - Thailand Existing Chemicals Inventory; TSCA - Toxic Substances Control Act(United States); UN - United Nations; UNRTDG - United Nations Recommendations on theTransport of Dangerous Goods; vPvB - Very Persistent and Very Bioaccumulative

Sources of key data used tocompile the Material Safety
Data Sheet:Internal technical data, data from raw material SDSs, OECD
eChem Portal search results and European Chemicals Agency, http://echa.europa.eu/

Revision Date:

09/29/2023

15 / 16

SAFETY DATA SHEET
according to the OSHA Hazard Communication Standard

Recombinant Follicle Stimulating Hormone
Formulation
Version
5.10

Revision Date:
09/29/2023

SDS Number:
26821-00023

Date of last issue: 04/04/2023
Date of first issue: 10/31/2014

The information provided in this Safety Data Sheet is correct to the best of our knowledge,
information and belief at the date of its publication. The information is designed only as a
guidance for safe handling, use, processing, storage, transportation, disposal and release andshall not be considered a warranty or quality specification of any type. The information provided
relates only to the specific material identified at the top of this SDS and may not be valid when the
SDS material is used in combination with any other materials or in any process, unless specified
in the text. Material users should review the information and recommendations in the specificcontext of their intended manner of handling, use, processing and storage, including anassessment of the appropriateness of the SDS material in the user’s end product, if applicable.
US / Z8

16 / 16